Fruktoza jako czynnik ryzyka przewleklych chorob metabolicznych

• Autorzy: Ciok J. , Tacikowski T. , Wyrobek I.

Warianty tytułu

EN

Fructose as a risk factor of chronic metabolic diseases

• Języki publikacji: PL

Słowa kluczowe

PL

choroby czlowieka; choroby metaboliczne; choroby przewlekle; czynniki chorobotworcze; ryzyko zachorowan; fruktoza; otylosc; hiperlipidemia; insulinoopornosc; nadcisnienie tetnicze

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2004
• Tom: 31
• Numer: 1
• Opis fizyczny: 88-95,rys.,bibliogr.

Twórcy

autor

Ciok J.

• Instytut Zywnosci i Zywienia, Warszawa

autor

Tacikowski T.

autor

Wyrobek I.

Bibliografia

• 1. Abraha A., Humphreys S.M., et. al.: Acute effect of fructose on postprandial lipaemia in diabetic and non-diabetic subjects. Br. J. Nutr., 1998, 80, 169-75.
• 2. Arner P: Free fatty acids - do they play a central role in type 2 diebetes? Diabetes Obes. Metab., 2001, 3 suppl :S11-19.
• 3. Astrup A., Raben A., Vasilaras T.H., Moller A.C.: Sucrose in soft drinks is fattening; a randomised 10 week study in overweight subjects. Am. J. Clin. Nutr., 2002, 75 Suppl: 405S (abstr).
• 4. Bantle J.E, Raatz S.K., Thomas W., Georgopulos A.: Effects of dietary fructose on plasma lipids in healthy subjcets. Am. J. Clin. Nutr., 2000, 72, 1128-34.
• 5. Bergman R.N., Ader M.: Free fatty acids and pathogenesis of type 2 diebetes. Trends Endocrinol. Metab., 2000,11, 351-6.
• 6. Blakely S.R., Hallfrisch J., Reiser S., Prather E.S.: Long- term effects of moderate fructose feeding on glucose tolerance parameters in rats. J. Nutr., 1981, 111, 307-14
• 7. Brand Miller J.: International tables of glycemic index and glycemic load. Am J. Clin. Nutr., 2002, Jul;76(l), 5-56.
• 8. Catena C., Giacchetti G., Novello M., et. al.: Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Am. J. Hypertens., 2003, 16, 973-8.
• 9. Coulston A.M., Johnson R.K.: Sugar and sugars: myths and realities. J. Am. Diet. Assoc., 2002, 102, 351-3.
• 10. Curry D.L.: Effects of mannose and fructose on the synthesis and secretion of insulin. Pancreas 1989, 4, 2-9.
• 11. Czyżyk A.: Zaburzenia przemiany węglowodanów. W: Nauka o chorobach wewnętrznych. Red. W. Orłowski t. IV Warszawa, PZWL, 1989, str.171-193.
• 12. Elliott S.S., Keim N.L., Stern J.S. et. al.: Fructose, weight gain, and the insulin resi- i stance syndrome. Am. J. Clin. Nutr., 2002, 76, 911-22.
• 13. Faroqi S., Keogh J.M, Kamath S.: Partial leptin deficiency and human adiposity. Nature 2001, 414, 34-: 5.
• 14. Fields M., Lewis C.G.: Dietary fructose but not starch is responsible for hyperlipidemia associated with copper deficiency in rats: effect of high-fat diet. J. Am. Coll. Nutr., 1999, 18, 83-7.
• 15. Fried S.K., Rao S.P: Sugars, hypertriglyceridemia, and cardiovascular disease. Am. J. Clin. Nutr., 2003, 78, 873S-880S.
• 16. Hallfrisch J., Reiser S., Prather E.S.: Blood lipid distribution of hyperinsulinemic men consuming three levels of fructose. Am. J. Clin. Nutr., 1983, 37, 740-8.
• 17. Havel J.P: Glucose but not fructose infusion increases circulating leptin in proportion to adipose stores in rhesus monkeys. Exp. Clin. Endocrin. Diabetes 1997, 105, 37-8.
• 18. Havel P.J., Elliott S.S., Tschoep M.: Consuming high fructose meals reduces 24 hour circulating insulin and leptin concentrations and does not suppress circulating ghrelin in women. J. Invest. Med., 2002, 50, 26A (abstr).
• 19. Havel P.J.: Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp. Biol. Med., 2001, 226, 963-77.
• 20. Hawkins M.A., Wozniak R., Gabriely I., et. al.: Fructose restores the ability of hyperglycemia per se to regulate hepatic glucose production (GP) in type 2 diabetes mellitus (DM2). Diabetes 1999, 48, A292 (abstr).
• 21. Haynes W.G., Morgan D.A., Walsh S.A., et. al.: Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest., 1997, 100, 270-8.
• 22. Hoilenbeck C.B.: Dietary fructose effects on lipoprotein metabolism and risk for coronary artery disease. Am. J. Clin. Nutr., 1993, 58, 800S-809S.
• 23. Jequier E., Tappy L.: Regulation of body weight in humans. Physiol. Rev., 1999, 79, 451-80.
• 24. Moore M.C., Mann S.L. Converse M., Penazola A.: Fructose decreases the glucose and insulin responses to an oral glucose tolerance test (OGTT) in individuals with type 2 diabetes (DM2). Diabetes 2000, 49, A84 (abstr).
• 25. Park Y.K., Yetley E.A.: Intakes and food sources of fructose in the United States. Am. J. Clin. Nutr., 1993, 58 suppl, 737S-47S.
• 26. Parks E.J. Hellerstein M.K.: Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am. J. Clin. Nutr., 2000, 71, 412-33.
• 27. Petersen K.F., Laurent D., Yu C., et. al.: Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. Diabetes 2001, 50, 1263-8.
• 28. Poppitt S.D., Keogh G.F. Prentice A.M.: Long-term effects of ad libitum low-fat. High-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am. J. Clin. Nutr., 2002, 75, 11-20.
• 29. Putnam J.J., Allshouse J.E.: Food consumption, prices, and expenditures, 1970 - 97. Washington D.C.: Economic Research Service, US Department of Agriculture, 1999.
• 30. Saad M.F., Khan A., Sharma A. et. al.: Physiological insulinemia acutely modulates plasma leptin. Diabetes 1998, 47, 544-9.
• 31. Schwartz J-M., Neese R.A., Turner S.M., et. al.: Effect of fructose ingestion on glucose production (GP) and de novo lipogenesis (DNL) in normal and hyperin- sulinemic obese humans. Diabetes 1994, 43 Suppl, 52A (abstr).
• 32. Schwartz M.W., Boyko E.J., Kahn S.E., et. al.: Reduced insulin secretion: an independent predictor of body weight gain. J. Clin. Endocrinol. Metab., 1995, 80, 1571-6.
• 33. Schwartz M.W., Woods S.C., Porte D. Jr, et. al.: Central nervous system control of food intake. Nature 2000, 404, 661-71.
• 34. Szponar L., Sekuła W., Rychlik E., Ołtarzewski M., Figur ska K: Badania indywidualnego spożycia żywności i stanu odżywienia w gospodarstwach domowych. Warszawa, Instytut Żywności i Żywienia, Prace IŻŻ 101, 2003.
• 35. Taghibiglou C., Carpenter A., Van Inderstine S.C.: Mechanisms of hepatic very low density lipoprotein overproduction in insulin resestance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J. Biol. Chem., 2000, 275, 8416-25.
• 36. Thorburn A.W., Storlien L.H., Jenkins A.B., et. al.: Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am. J. Clin. Nutr., 1989, 49, 1155-63.
• 37. Tordoff M.G., Alleva A.M.: Effect of drinking soda sweetend with aspartame or high-fructose corn syrup on food intake and body weight. Am. J. Clin. Nutr., 1990, 51, 963-9.
• 38. Tremblay A., Plourde G., Despres J.P, Bouchard C.: Impact of dietary fat content and fat oxidation on energy intake in humans. Am. J. Clin. Nutr., 1989, 49, 799-805.
• 39. Weyer C., Funahashi T., Tanaka S.: Hypoadiponectinemia in obesity and type 2 diebetes: close association with insulin resistance and hyperinulinemia. J. Clin. Endocrinol. Metab., 2001, 86, 1930-5.